Clinical Trial Update: Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

Metformin is being repurposed for oral submucous fibrosis, with reported in vitro signaling work and progression to Phase 1/Phase 2 clinical trials. The trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Submucous Fibrosis

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Ziauddin University | Conditions: Oral Submucous Fibrosis | Phase 1, Phase 2 | Status: COMPLETED